Rigel Pharmaceuticals | RIGL - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Rigel Pharmaceuticals

Rigel Pharmaceuticals reported $1.4M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.


Pre Tax Profit Change
Agenus AGEN:US USD -70893000 3.21M
Anika Therapeutics ANIK:US USD -12014000 5.62M
Arrowhead Research ARWR:US USD 47.68M 89.47M
AstraZeneca AZN:LN USD 3.71B 1.41B
Celldex Therapeutics CLDX:US USD -29361000 2.87M
Daiichi Sankyo 4568:JP JPY -596000000 36.78B
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Immunogen IMGN:US USD -41014000 16.78M
Intrexon XON:US USD -22789000 621K
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Karyopharm Therapeutics KPTI:US USD -34072000 4.36M
MacroGenics MGNX:US USD -38009000 50.81M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
Sangamo BioSciences SGMO:US USD 21.33M 73.04M
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M
Veracyte VCYT:US USD -8091000 4.65M